I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022
May 10, 2021
Share
I'rom Group Co., Ltd. announced dividend of ¥20.00 per share for the year Ended March 31, 2021 compared to ¥20.00 per share paid in last year. Expected starting date of dividend payment is June 29, 2021.
The company provided dividend guidance for the second quarter and fiscal year 2022. For the quarter, the company expects to pay dividend of ¥20.00 per share compared to ¥20.00 per share paid in last year.
For the year ending March 31, 2022, the company provided dividend guidance for the second quarter and fiscal year 2022. For the quarter, the company expects to pay dividend of ¥20.00 per share compared to ¥20.00 per share announced in last year.
I'rom Group Co.,Ltd. is engaged in medical fields such as regenerative medicine and gene discovery. The Company operates through four business segments. The SMO segment provides support services for contracting or substituting a part of the work related to conducting clinical trials from the conducting medical institution. The CRO segment provides all or part of clinical trial operations from pharmaceutical companies and others. The Advanced Medicinal Treatment segment is engaged in the development of gene therapy products, the development, manufacture and sale of products in the field of regenerative medicine based on iPS cells related technologies, as well as the provision of contract manufacture services. The Medical Support segment provides general and comprehensive support for medical business management, such as setting up and renting clinic malls, selling products and related services. The Company also provides business utilizing IT infrastructure.
I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022